Potential CAR-T treatment centers announced (England)

Thank you to my NHS England Cancer Pharmacist colleagues for sharing the Information on the ‘potential’ treatment sites for delivery of CAR-T therapy in England.  As yet we are unaware of potential sites in the rest of the home nations, so would be grateful if BOPA members can share any relevant information on this exciting new cancer treatment via our forums or via email to [email protected] so we can share

NHS England is pleased to confirm that the following 8 centres have been selected for the first JACIE inspections for accreditation in delivering Immune Effector Cell therapy, based on their submissions, geographical access and advice from JACIE and industry partners:
 
•         Great Ormond Street Hospital NHS Foundation Trust     
•         King’s College Hospital NHS Foundation Trust     
•         Manchester University Hospitals NHS Foundation Trust (MRI /Royal Manchester Children’s Hospital)     
•         The Christie NHS Foundation Trust
•         The Newcastle Upon Tyne Hospitals NHS Foundation Trust         
•         University College London Hospitals NHS Foundation Trust
•         University Hospitals Birmingham NHS Foundation Trust                
•         University Hospitals Bristol NHS Foundation Trust
 
Further instructions are being sent to the sites identified for inspection.
 
This is the first phase of a national implementation of CAR T cell therapy with further phases expected in due course.
 
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article